Serum Institute Seeks Indemnity, Says "Same Rules For All": Sources | Read

PUBLISHED ON: June 3, 2021 | Duration: 1 min, 49 sec

  
loading..
After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources. All vaccine makers, whether Indian or foreign, should be granted the same protection, the Adar Poonawalla-led company has reportedly told the government. "Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it," Serum sources said today. "Serum is hoping that rules should be same for everyone," the sources added.
ALSO WATCH
The Covishield vs EU Controversy

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com